Page last updated: 2024-11-08

dimethylmyleran and Hepatic Veno Occlusive Disease

dimethylmyleran has been researched along with Hepatic Veno Occlusive Disease in 2 studies

dimethylmyleran: RN given refers to cpd without isomeric designation
dimethylmyleran : A methanesulfonate ester that is hexane-2,5-diol in which the hydrogens of the hydroxy groups are replaced by methanesulfonyl groups.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shulman, HM2
Luk, K1
Deeg, HJ1
Shuman, WB1
Storb, R2
Kanfer, EJ1
Buckner, CD1
Fefer, A1
Appelbaum, FR1
Hill, RS1
Amos, D1
Doney, KC1
Clift, RA1

Other Studies

2 other studies available for dimethylmyleran and Hepatic Veno Occlusive Disease

ArticleYear
Induction of hepatic veno-occlusive disease in dogs.
    The American journal of pathology, 1987, Volume: 126, Issue:1

    Topics: Animals; Busulfan; Buthionine Sulfoximine; Cyclophosphamide; Disease Models, Animal; Dog Diseases; D

1987
Allogeneic and syngeneic marrow transplantation following high dose dimethylbusulfan, cyclophosphamide and total body irradiation.
    Bone marrow transplantation, 1987, Volume: 1, Issue:4

    Topics: Adolescent; Adult; Bone Marrow Transplantation; Busulfan; Child; Child, Preschool; Cyclophosphamide;

1987